Autolus Therapeutics plc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| WELLINGTON MANAGEMENT GROUP LLP | 02/12/2025 | 25.35 M | $59.56 M | 4.65% | 9.53% |
| BLACKSTONE INC. | 02/14/2025 | 20.49 M | $48.14 M | 0.00% | 7.70% |
| SYNCONA PORTFOLIO LTD | 02/06/2025 | 16.64 M | $39.11 M | -10.32% | 6.25% |
| FMR LLC | 02/13/2025 | 15.63 M | $36.74 M | -12.05% | 5.87% |
| DEEP TRACK CAPITAL, LP | 02/14/2025 | 14.22 M | $33.41 M | -6.90% | 5.34% |
| AVORO CAPITAL ADVISORS LLC | 02/14/2025 | 9.91 M | $23.29 M | -19.72% | 3.72% |
| ARMISTICE CAPITAL, LLC | 02/14/2025 | 9.20 M | $21.62 M | 33.88% | 3.46% |
| TFG ASSET MANAGEMENT GP LTD | 02/21/2025 | 8.25 M | $19.39 M | 3.13% | 3.10% |
| FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | 02/18/2025 | 4.62 M | $10.86 M | 0.00% | 1.74% |
| AFFINITY ASSET ADVISORS, LLC | 02/13/2025 | 4.50 M | $10.58 M | 0.00% | 1.69% |
| BLACKROCK FUNDING, INC. /DE | 02/07/2025 | 4.13 M | $9.70 M | -6.73% | 1.55% |
| CANDRIAM S.C.A. | 02/07/2025 | 3.19 M | $7.50 M | 100.00% | 1.20% |
| LAURION CAPITAL MANAGEMENT LP | 02/14/2025 | 3.19 M | $7.50 M | 0.00% | 1.20% |
| GREAT POINT PARTNERS LLC | 02/14/2025 | 3.01 M | $7.07 M | 7.02% | 1.13% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 02/14/2025 | 2.94 M | $6.91 M | -23.49% | 1.10% |
| SCHRODER INVESTMENT MANAGEMENT GROUP | 02/12/2025 | 2.86 M | $6.33 M | 0.00% | 1.08% |
| AXA S.A. | 02/14/2025 | 1.82 M | $4.29 M | 100.00% | 0.69% |
| BANK OF NEW YORK MELLON CORP | 02/04/2025 | 1.67 M | $3.93 M | -8.55% | 0.63% |
| MILLENNIUM MANAGEMENT LLC | 02/14/2025 | 1.65 M | $3.89 M | 91.61% | 0.62% |
| PERPETUAL LTD | 01/17/2025 | 1.28 M | $3.01 M | -19.99% | 0.48% |
| JPMORGAN CHASE & CO | 02/12/2025 | 1.07 M | $2.52 M | -16.59% | 0.40% |
| ROCK SPRINGS CAPITAL MANAGEMENT LP | 02/14/2025 | 1.03 M | $2.43 M | 0.00% | 0.39% |
| TWO SIGMA INVESTMENTS, LP | 02/14/2025 | 906,767 | $2.13 M | 23.83% | 0.34% |
| MARSHALL WACE, LLP | 02/13/2025 | 757,535 | $1.78 M | 0.00% | 0.28% |
| ALPHABET INC. | 02/07/2025 | 698,262 | $1.64 M | 0.00% | 0.26% |
| 02/12/2025 | 636,979 | $1.50 M | 146.96% | 0.24% | |
| RENAISSANCE TECHNOLOGIES LLC | 02/13/2025 | 618,942 | $1.45 M | 146.72% | 0.23% |
| DAFNA CAPITAL MANAGEMENT LLC | 02/14/2025 | 586,667 | $1.38 M | 20.55% | 0.22% |
| HIGHVISTA STRATEGIES LLC | 02/14/2025 | 533,024 | $1.25 M | 0.00% | 0.20% |
| HEALTHINVEST PARTNERS AB | 02/04/2025 | 479,644 | $1.06 M | 8.41% | 0.18% |
| CETERA INVESTMENT ADVISERS | 02/14/2025 | 356,222 | $837,122 | 169.87% | 0.13% |
| TWO SIGMA ADVISERS, LP | 02/14/2025 | 333,400 | $783,490 | 4.84% | 0.13% |
| MAI CAPITAL MANAGEMENT | 02/14/2025 | 328,326 | $771,567 | -0.28% | 0.12% |
| LEGAL & GENERAL GROUP PLC | 02/13/2025 | 297,736 | $697,039 | 392.03% | 0.11% |
| WELLS FARGO & COMPANY/MN | 02/13/2025 | 266,315 | $625,841 | -30.98% | 0.10% |
| HENNION & WALSH ASSET MANAGEMENT, INC. | 01/15/2025 | 259,980 | $610,953 | 100.00% | 0.10% |
| STATE STREET CORP | 02/14/2025 | 256,530 | $602,846 | -57.71% | 0.10% |
| POINT72 ASSET MANAGEMENT, L.P. | 02/14/2025 | 247,089 | $580,659 | 100.00% | 0.09% |
| PRIVIUM FUND MANAGEMENT B.V. | 02/11/2025 | 231,674 | $544,434 | 24.80% | 0.09% |
| ALPS ADVISORS INC | 02/13/2025 | 215,190 | $505,697 | 100.00% | 0.08% |
| UBS GROUP AG | 02/14/2025 | 200,232 | $470,545 | 27.55% | 0.08% |
| 02/10/2025 | 195,000 | $440,700 | 0.00% | 0.07% | |
| ENTRYPOINT CAPITAL, LLC | 02/11/2025 | 191,429 | $449,858 | 100.00% | 0.07% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 02/14/2025 | 158,685 | $372,910 | -56.52% | 0.06% |
| VONTOBEL HOLDING LTD. | 01/30/2025 | 147,419 | $346,435 | -26.64% | 0.06% |
| GOLDMAN SACHS GROUP INC | 02/11/2025 | 126,230 | $296,641 | 110.34% | 0.05% |
| EVERSEPT PARTNERS, LP | 02/14/2025 | 98,895 | $232,403 | -75.68% | 0.04% |
| CLEARSTEAD ADVISORS, LLC | 02/10/2025 | 91,107 | $214,102 | -5.20% | 0.03% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/14/2025 | 89,100 | $209,385 | 607.14% | 0.03% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/12/2025 | 86,256 | $202,701 | 0.00% | 0.03% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Autolus Therapeutics plc institutional Ownership - FAQ's
During the previous two years, 125 institutional investors and hedge funds held shares of Autolus Therapeutics plc. The most heavily invested institutionals were:
WELLINGTON MANAGEMENT GROUP LLP: 25.35 M
Blackstone Inc.: 20.49 M
Syncona Portfolio Ltd: 16.64 M
FMR LLC: 15.63 M
Deep Track Capital, LP: 14.22 M
Avoro Capital Advisors LLC: 9.91 M
63.25% of Autolus Therapeutics plc stock is owned by institutional investors.
Institutional investors have bought a total of 179.86 M shares in the last 24 months. This purchase volume represents approximately $467.64 M in transactions.